|
 CHICAGO (AP) - Health care products maker Abbott Laboratories Inc. posted a 38 percent gain in second-quarter profit Wednesday, but its stock fell after the company forecast third-quarter earnings below Wall Street's expectations.
Strong sales of diagnostic products and rheumatoid arthritis drug Humira helped net income climb to $877.1 million, or 56 cents per share, from $634.3 million, or 40 cents per share, a year ago.
Excluding one-time items, Abbott's earnings from continuing operations were 58 cents per share, a penny higher than the average estimate from analysts surveyed by Thomson Financial.
|